Ekso Bionics Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton
Latest Healthcare Technology Updates from HNC Healthcare News Channel
It is our mission to make EksoNR accessible to as many people as possible. We are excited to expand our indications for use to include those living with multiple sclerosis.
Multiple sclerosis is a neurological disease where the immune system attacks the central nervous system. It is one of the leading causes of disability in young adults and affects more than 1 million people in the US and over 2.8 million people worldwide. There has been a 50% increase in incidence over the last 10 years.
Over-exertion can lead to disease advancement and with EksoNR you can uniquely program the device to offer increased dosage which leads to increased activity tolerance and improved functional outcomes and quality of life indicators. EksoNR is particularly beneficial for this population to support therapeutic goals and improved outcomes have been reported including balance, coordination, endurance, gait training and quality of life.
LinkedIn Post Link: